Delivery Order SPE2DB20D7059-SPE2DB25FQEN2
Award Date
4/23/25
Potential Completion Date
4/24/25
Potential Value
$1.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,589.87 firm-fixed-price contract is for the supply of 4,568,075,812 doses of the vaccine TYPHIM VI 25 MCG/0.5 ML VIAL 10ML. The delivery order has an ultimate completion date of April 30, 2025. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which...
This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for 4,567,202,673 units of the TYPHIM VI 25 MCG/0.5 ML VIAL 10ML vaccine, with a ceiling value of $5,044.30. The contract has a firm fixed price and a completion date of February 10, 2025. This order is placed under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds...
This is a $39,598.42 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The order is for the supply of 4,565,235,791 units of the TYPHIM VI 25 MCG/0.5 ML VIAL 10ML vaccine. The contract has a period of performance through July 25, 2024 and was awarded on July 24, 2024. AmerisourceBergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,670,234 units of the TYPHIM VI 25 MCG/0.5 ML VIAL 10ML vaccine, with a ceiling value of $2,879.76. The contract has a Firm Fixed Price pricing type and is a Delivery Order. The contract has an ultimate completion date of March 24, 2025. The contract does not have a set-aside...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $5,179.74, is for the delivery of 4,568,099,867 units of the vaccine TYPHIM VI 25 MCG/0.5 ML VIAL 10ML. The contract is a firm fixed-price delivery order without a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,183,176 units of the TYPHIM VI 25 MCG/0.5 ML VIAL 10ML vaccine. The contract has a ceiling value of $37,452.40 and a period of performance through April 8, 2024. This delivery order appears to be part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued at up to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,568,141,650 units of the vaccine TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML. The contract is a firm fixed-price delivery order with a ceiling value of $3,449.50 and an ultimate completion date of May 6, 2025. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,568,177,989 units of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a vaccine product. The contract has a firm fixed price of $8,724.50 and a completion date of May 8, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of 4,563,519,182 units of the TYPHIM VI 25 MCG/0.5 ML VIAL 10ML vaccine, with a total ceiling value of $2,564.45. The contract is a firm fixed-price delivery order with a period of performance through February 2, 2024. This award is not designated as a...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $5,617.86 contract is for the provision of 4,563,955,495 units of the vaccine TYPHIM VI 25 MCG/0.5 ML VIAL 10ML. The delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and...